Research & Development
Health Topics: Page 3
Cell-free DNA methylation blood test predicts risk of early-onset preeclampsia
Cell-free DNA methylation profiling may support the presymptomatic assessment of preeclampsia (PE) risk, according to a paper published on August 28 in Nature Medicine.
August 30, 2023
C2N Diagnostics rolls out second-generation Alzheimer's disease biomarker test
C₂N Diagnostics has unveiled its “next generation” blood biomarker test to evaluate patients with signs and symptoms of Alzheimer’s disease (AD) and other causes of cognitive decline.
August 29, 2023
AI neuroimaging model aims to predict neuropathic pain treatment responses
A magnetic resonance (MR) neuroimaging model which uses artificial intelligence (AI) to identify new biomarkers could lead to more effective medical treatment for chronic nerve pain, say the researchers developing the model.
August 25, 2023
CRISPR-Cas3 technique restores dystrophin function in iPSCs from DMD patients
Researchers have developed a dual CRISPR-Cas3 gene editing technique to restore dystrophin function in induced pluripotent stem cells (iPSCs) from patients with Duchenne muscular dystrophy (DMD).
August 24, 2023
Exploratory trial links kinase inhibitor to epigenetic changes in dementia patients
Results from a clinical trial show that a small molecule that binds to kinases involved in inflammatory signaling may induce epigenetic changes in people with mild cognitive impairment and probable Alzheimer’s disease.
August 22, 2023
AI system in development aims for earlier endometriosis diagnosis
IMAGENDO uses machine learning to digitally combine the diagnostic capabilities of pelvic scans and MRI to identify endometriosis lesions. The researchers are seeking to optimize and validate the algorithm.
August 21, 2023
Messenger RNA shows preclinical promise as in vivo gene editing treatment for sickle cell
The delivery of the editing system resulted in the near-complete correction of hematopoietic sickle cells. A preclinical test linked the approach to a 91.7% increase in functional hemoglobin and a significant fall in the number of sickled cells.
August 14, 2023
PacBio, GeneDx team up to test if long-read sequencing improves pediatric diagnoses
In the study, GeneDx, a genetic testing company, will use PacBio’s Revio sequencing system to perform WGS and analysis of samples from 350 people and their biological parents.
August 10, 2023
Quest Diagnostics launches consumer-initiated Alzheimer’s risk assessment test
The new test uses the same technology as Quest's clinical AD-Detect Amyloid Beta 42/40 Ratio biomarker test for assessing amyloid beta protein, a recognized marker for Alzheimer’s, which was made available for physicians in early 2022.
August 1, 2023
Cumulus Neuroscience partners with U.K. universities on cognition test for early Alzheimer’s diagnosis
The partnership will look to scale the development and testing of the Fastball EEG test, which uses an EEG headset to measure brain activity while patients watch a series of flashing images displayed on a tablet or smartphone screen.
July 25, 2023
Thermo Fisher launches first reproductive health assays on Ion Torrent sequencer
The products, the Ion ReproSeq PGT-A Kit and the Ion AmpliSeq Polyploidy Kit, are the first reproductive health assays available for the company’s Ion Torrent Genexus Integrated Sequencer.
July 21, 2023
Analysis of 462M lipid test results reveals global variation in cholesterol levels
Mean total cholesterol levels exceeded the World Health Organization (WHO) target in seven of the 17 countries included in the analysis, namely Japan, Australia, North Macedonia, Switzerland, Germany, Slovakia, and Austria.
July 17, 2023
Page 3 of 66